New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.
Benini V, Ruffolo AF, Casiraghi A, Degliuomini RS, Frigerio M, Braga A, Serati M, Torella M, Candiani M, Salvatore S.
Medicina (Kaunas). 2022 Jun 6;58(6):770. doi: 10.3390/medicina58060770.
PMID:35744033
The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
Clin Breast Cancer. 2019 Dec;19(6):e731-e740. doi: 10.1016/j.clbc.2019.07.007. Epub 2019 Aug 21.
PMID:31522958
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.
Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA.